Osiris Therapeutics, Inc. (NASDAQ: OSIR), announced today that data from an evaluation of Grafix in the treatment of chronic venous leg ulcers (VLUs) was presented on Sunday September 14th, at the joint annual meeting of the Eastern Vascular Society and the New England Society for Vascular Surgery.
Help employers find you! Check out all the jobs and post your resume.
